215 related articles for article (PubMed ID: 16817642)
21. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
Moriya M; Nakatsuji Y; Okuno T; Hamasaki T; Sawada M; Sakoda S
J Neuroimmunol; 2005 Dec; 170(1-2):11-20. PubMed ID: 16146654
[TBL] [Abstract][Full Text] [Related]
22. IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation.
Beyeen AD; Adzemovic MZ; Ockinger J; Stridh P; Becanovic K; Laaksonen H; Lassmann H; Harris RA; Hillert J; Alfredsson L; Celius EG; Harbo HF; Kockum I; Jagodic M; Olsson T
J Immunol; 2010 Dec; 185(11):6883-90. PubMed ID: 21041731
[TBL] [Abstract][Full Text] [Related]
23. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
[TBL] [Abstract][Full Text] [Related]
24. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
Parvaneh Tafreshi A
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
[TBL] [Abstract][Full Text] [Related]
25. Changes in characteristics of rat skeletal muscle after experimental allergic encephalomyelitis.
de Haan A; van der Vliet MR; Hendriks JJ; Heijnen DA; Dijkstra CD
Muscle Nerve; 2004 Mar; 29(3):369-75. PubMed ID: 14981735
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells.
Cavaletti G; Perseghin P; Dassi M; Oggioni N; Sala F; Braga M; Lolli F; Riccio P; Carlone G; Zoia C; Tagliabue E; Stanzani L; Galbiati S; Rigamonti L; Marmiroli P; Ferrarese C; Frattola L; Tredici G
J Biol Regul Homeost Agents; 2004; 18(1):9-17. PubMed ID: 15323355
[TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis: human model for EAE?
Hohlfeld R
Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
29. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
Mao YS; Lu CZ; Wang X; Xiao BG
Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
[TBL] [Abstract][Full Text] [Related]
30. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis.
Shin T; Kim H; Jin JK; Moon C; Ahn M; Tanuma N; Matsumoto Y
J Neuroimmunol; 2005 Aug; 165(1-2):11-20. PubMed ID: 15925413
[TBL] [Abstract][Full Text] [Related]
31. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis.
Lassmann H
Schriftenr Neurol; 1983; 25():1-135. PubMed ID: 6605578
[No Abstract] [Full Text] [Related]
32. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
[TBL] [Abstract][Full Text] [Related]
33. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
34. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
Zozulya AL; Wiendl H
Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
[TBL] [Abstract][Full Text] [Related]
35. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
36. Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: an ultrastructural study.
Shikishima K; Lee WR; Behan WM; Foulds WS
Exp Eye Res; 1993 Feb; 56(2):167-75. PubMed ID: 8462650
[TBL] [Abstract][Full Text] [Related]
37. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis.
Wildbaum G; Karin N
Gene Ther; 1999 Jun; 6(6):1128-38. PubMed ID: 10455416
[TBL] [Abstract][Full Text] [Related]
39. [Experimental autoimmune encephalomyelitis].
Cornet A; Vizler C; Liblau R
Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
[TBL] [Abstract][Full Text] [Related]
40. Effects of GSM-900 microwaves on the experimental allergic encephalomyelitis (EAE) rat model of multiple sclerosis.
Anane R; Geffard M; Taxile M; Bodet D; Billaudel B; Dulou PE; Veyret B
Bioelectromagnetics; 2003 Apr; 24(3):211-3. PubMed ID: 12669305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
